ReutersGB
SCI & TECH United KingdomUnited States
AstraZeneca gets US nod for expanded Imfinzi use, new rare-disease therapy
Covered by 1 source
SCI & TECH United KingdomUnited States
Covered by 1 source
ReutersGB